Hot Pursuit     18-Dec-23
Zydus Lifesciences Ltd spurts 4%, up for fifth straight session
Zydus Lifesciences Ltd is quoting at Rs 671.75, up 4% on the day as on 12:44 IST on the NSE. The stock is up 64.14% in last one year as compared to a 16.44% jump in NIFTY and a 29.59% jump in the Nifty Pharma.

Zydus Lifesciences Ltd is up for a fifth straight session today. The stock is quoting at Rs 671.75, up 4% on the day as on 12:44 IST on the NSE. The benchmark NIFTY is down around 0.03% on the day, quoting at 21449.3. The Sensex is at 71428.87, down 0.08%. Zydus Lifesciences Ltd has gained around 5.62% in last one month.

Meanwhile, Nifty Pharma index of which Zydus Lifesciences Ltd is a constituent, has gained around 3.68% in last one month and is currently quoting at 16179.8, up 1.29% on the day. The volume in the stock stood at 49.43 lakh shares today, compared to the daily average of 11.55 lakh shares in last one month.

The benchmark December futures contract for the stock is quoting at Rs 674.05, up 3.96% on the day. Zydus Lifesciences Ltd is up 64.14% in last one year as compared to a 16.44% jump in NIFTY and a 29.59% jump in the Nifty Pharma index.

The PE of the stock is 26.24 based on TTM earnings ending September 23.

Previous News
  Zydus Lifesciences gains after launching Denosumab Biosimilar
 ( Hot Pursuit - 10-Dec-25   11:27 )
  Zydus launches Zyrifa - a Denosumab biosimilar
 ( Corporate News - 10-Dec-25   10:19 )
  Zydus Lifesciences receives EIR for facility at Jarod, Vadodara
 ( Corporate News - 04-Dec-25   15:48 )
  Zydus Life gets US FDA nod for generic version of antidiabetic combination drug Glyxambi
 ( Hot Pursuit - 28-Nov-25   09:21 )
  Zydus Life rises after inking exclusive licensing deal with RK Pharma for US oncology product
 ( Hot Pursuit - 26-Nov-25   13:30 )
  Zydus enters into licensing and commercialization agreement with RK Pharma Inc.
 ( Corporate News - 26-Nov-25   13:15 )
  Zydus Lifesciences Ltd rises for third consecutive session
 ( Hot Pursuit - 26-Nov-25   13:05 )
  Stock Alert: Zydus Lifescience, United Breweries, Nelco, NCC, Refex Inds
 ( Market Commentary - Stock Alert 26-Nov-25   07:50 )
  Zydus receives USFDA approval for Verapamil Hydrochloride Extended-Release Tablets
 ( Corporate News - 25-Nov-25   19:30 )
  Zydus Lifesciences
 ( Analyst Meet / AGM - Conference Call 18-Nov-25   12:13 )
  Zydus receives USFDA approval for Leuprolide Acetate injection
 ( Corporate News - 14-Nov-25   18:49 )
Other Stories
  United Drilling Tools secures Rs 3-cr export order from Nigeria
  13-Dec-25   16:06
  Biocon’s arm inks pact to commercialize biosimilar Aflibercept Worldwide
  13-Dec-25   15:17
  GPT Infraprojects secures Rs 54 crore order from South Eastern Railway
  13-Dec-25   12:22
  KEC International bags Rs 1,150-cr orders in T&D and civil businesses
  13-Dec-25   11:58
  Astra Microwave Products bags Rs 124 crore order
  13-Dec-25   11:35
  Oriental Rail Infra’s arm bags Rs 1-cr order from North Western Railway
  13-Dec-25   10:18
  Refex Industries Ltd leads losers in 'A' group
  12-Dec-25   15:00
  Kranti Industries gains after securing Rs 35-lakh defence order from AVNL–MTPF
  12-Dec-25   14:49
  VLS Finance Ltd leads losers in 'B' group
  12-Dec-25   14:45
  PNB Housing Finance climbs after appointing Ajai Shukla as MD & CEO
  12-Dec-25   14:37
Back Top